Prosecution Insights
Last updated: April 19, 2026

Insilico Medicine Ip Limited

4 pending office actions

Portfolio Summary

4
Total Pending OAs
2
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18049757 SARS-COV-2 INHIBITORS HAVING COVALENT MODIFICATIONS FOR TREATING CORONAVIRUS INFECTIONS HAVLIN, ROBERT H 1626 Final Rejection Oct 26, 2022
17911376 RETROSYNTHESIS-RELATED SYNTHETIC ACCESSIBILITY SKIBINSKY, ANNA 1635 Non-Final OA Sep 13, 2022
17835167 ADVERSARIAL FRAMEWORK FOR MOLECULAR CONFORMATION SPACE MODELING IN INTERNAL COORDINATES LUO, JAMMY NMN 1686 Non-Final OA Jun 08, 2022
17596888 SYNTHETIC BIOLOGICAL CHARACTERISTIC GENERATOR BASED ON REAL BIOLOGICAL DATA SIGNATURES KALLAL, ROBERT JAMES 1685 Final Rejection Dec 20, 2021

Managing Insilico Medicine Ip Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month